Last Update
May 19, 2018
Blüpass will revolutionize access to data, healthcare, and the claims process for everyone. We began our experience by administering benefits in a unique way. Our billing reconciliation process, HRaspirin, eliminated headaches between HR professionals and carriers. We spent six years in this space developing strong relationships. As good as our product was, it only solved for one side of a broken equation. This prompted us to create Blüpass, a total solution.
Blüpass will build a blockchain fabric to connect providers, consumers, and carriers.
The Blupass team has built a Minimal Viable Product called HRaspirin. HRaspirin has unique technology that processes insurance premiums for employers and carriers. The HRaspirin product has five years of history averaging $500,000 in revenue. This technology provides us with insurance data and policy information. HRaspirin is being integrated to the Blupass platform as we continue building blockchain technologies to solve insurance claims.
2018 Q3
2018 Q4
2019 Q1
2019 Q2
2019 Q3
2019 Q4
Verified 11%
Attention. There is a risk that unverified members are not actually members of the team
This offer is based solely on information provided by the offeror and other publicly available sources.
The token sale or exchange event is completely independent of ICOholder. ICOholder is not involved in any way, including technical support or promotion.
We list token sales from entities with which we have no relationship to help users track overall activity within the token sector. This information is not intended as advice, and you should seek professional or specialist guidance or conduct your own due diligence before making any decisions based on our content.
Any terms and conditions regarding token acquisition are solely between contributors and the token issuer. ICOholder is not the seller of these tokens.
ICOholder is not legally responsible for any representations made by third parties about any token sale. Any claims for breach of contract must be directed against the listed token issuing entity.
If you have concerns about the nature, legality, or propriety of a token sale or the involved individuals, please contact info@icoholder.com with detailed information.